Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Noninvasive Hemoglobin Monitor Uses Occlusion Spectroscopy Technology

By LabMedica International staff writers
Posted on 30 Jun 2011
A noninvasive hemoglobin (Hb) monitor, which measures key blood parameters, reduces the risk of a technician's contact with donor blood. More...


The portable noninvasive device operates via a ring-shaped sensor that is fitted on the donor's finger. The device applies pressure, temporarily gently squeezing the finger to over-systolic pressure, similar to blood pressure measurements, thus occluding local blood flow. During the occlusion, optical elements in the sensor, using an array of calibrated light sources, measure absorption, and scattering of the light transmitted through the finger.

Called occlusion spectroscopy, the method provides a quick, accurate, and painless measurement of the donor's blood constituents, while improving the donor's comfort, reducing infection risk, and providing the medical staff with accurate readings and immediate results.

Developed by OrSense Ltd. (Nes Ziona, Israel) the new device will allow donors to undergo blood testing without the need for a finger prick. The noninvasive method will also increase donor and staff safety. The hemoglobin/hematocrit monitor was granted CE approval and was tested on over 8,000 patients and donors at more than 20 sites in the United States and Europe.

OrSense noninvasive Hb monitor performance was highlighted in a study presented during the Euroanesthesia 2011 conference of the European Society of Anesthesia, held in Amsterdam (The Netherlands) from June 11-14, 2011. The study, directed by Prof. P. Singer from the general ICU Rabin Medical Center (Petah Tiqva, Israel) and Aharon Weinstein from OrSense, showed that OrSense's device was able to track accurately rapid changes in Hb levels, and maintained reliability even at very low Hb blood content.

In a statement on World Blood Donors Day, Dr. Emma Castro, CEO of the Transfusion Center of the Spanish Red Cross (Madrid, Spain), said, "A noninvasive system for the measurement of predonation Hb is eagerly awaited by both donors and staff. Our donors are very excited about the implementation of the new OrSense system and we are looking at it as a tool that will contribute to enlarge our blood donor community."

The U.S. Food and Drug Administration (FDA; Silver Spring, MD, USA) gave clearance for the OrSense noninvasive multiparameter monitor for continuous and spot measurement of normal and low signal oximetry for use in hospitals and outpatient sites. The company's CE approved glucose monitor was tested on over 450 diabetic subjects, showing performance similar to those of invasive glucose sensors.

Related Links:
OrSense
European Society of Anesthesia
Rabin Medical Center


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.